Search research articles
Contact Us
Filters
Showing results (261-270 of 286) with videos related to
Page
of 29
Sort By:
European Review for Medical and Pharmacological Sciences
|
July 17, 2023
Prevalence of urinary incontinence among women in Saudi Arabia: a cross-sectional study
A Thabet, K Battecha, M Alayat, et al.
AMB Express
|
July 6, 2023
Antimicrobial, antiproliferative activities and molecular docking of metabolites from Alternaria alternata
Heba T Khazaal, Mohamed T Khazaal, Ahmed S Abdel-Razek, et al.
Medicina (Kaunas, Lithuania)
|
September 28, 2021
The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival
Dina A Ali, Dina M El-Guindy, Mohamed A Elrashidy, et al.
Blood
|
September 14, 2010
Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy
Amr R Ibrahim, Christos Paliompeis, Marco Bua, et al.
BMC Plant Biology
|
May 29, 2024
Enhancing salt stress tolerance in wheat (Triticum aestivum) seedlings: insights from trehalose and mannitol
Abdulrahman M Alhudhaibi, Mervat A R Ibrahim, Seham M S Abd-Elaziz, et al.
Journal of Biochemical and Molecular Toxicology
|
June 23, 2026
Cardioprotective Effect of Aloin Against Ischemia/Reperfusion Injury: Experimental and Computational POM Approaches
Mounime Kadi, Taibi Ben Hadda, Faisal A Almalki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2011
Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
David Marin, Amr R Ibrahim, Claire Lucas, et al.
American Journal of Human Genetics
|
November 16, 2004
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations
F Bergametti, C Denier, P Labauge, et al.
BMC Medicine
|
December 19, 2024
The burden and clinical trajectory of immune checkpoint inhibitor-induced endocrinopathies: an 8-year experience
Fateen Ata, Adeel Ahmad Khan, Emad Algorani, et al.
Protein Expression and Purification
|
April 23, 2022
Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25, by silkworm and its biochemical analysis
Takeshi Miyata, Kosuke Minamihata, Koichi Kurihara, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 286) with videos related to
Sort By:
Page
of 29
European Review for Medical and Pharmacological Sciences
|
July 17, 2023
Prevalence of urinary incontinence among women in Saudi Arabia: a cross-sectional study
A Thabet, K Battecha, M Alayat, et al.
AMB Express
|
July 6, 2023
Antimicrobial, antiproliferative activities and molecular docking of metabolites from Alternaria alternata
Heba T Khazaal, Mohamed T Khazaal, Ahmed S Abdel-Razek, et al.
Medicina (Kaunas, Lithuania)
|
September 28, 2021
The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival
Dina A Ali, Dina M El-Guindy, Mohamed A Elrashidy, et al.
Blood
|
September 14, 2010
Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy
Amr R Ibrahim, Christos Paliompeis, Marco Bua, et al.
BMC Plant Biology
|
May 29, 2024
Enhancing salt stress tolerance in wheat (Triticum aestivum) seedlings: insights from trehalose and mannitol
Abdulrahman M Alhudhaibi, Mervat A R Ibrahim, Seham M S Abd-Elaziz, et al.
Journal of Biochemical and Molecular Toxicology
|
June 23, 2026
Cardioprotective Effect of Aloin Against Ischemia/Reperfusion Injury: Experimental and Computational POM Approaches
Mounime Kadi, Taibi Ben Hadda, Faisal A Almalki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2011
Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
David Marin, Amr R Ibrahim, Claire Lucas, et al.
American Journal of Human Genetics
|
November 16, 2004
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations
F Bergametti, C Denier, P Labauge, et al.
BMC Medicine
|
December 19, 2024
The burden and clinical trajectory of immune checkpoint inhibitor-induced endocrinopathies: an 8-year experience
Fateen Ata, Adeel Ahmad Khan, Emad Algorani, et al.
Protein Expression and Purification
|
April 23, 2022
Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25, by silkworm and its biochemical analysis
Takeshi Miyata, Kosuke Minamihata, Koichi Kurihara, et al.
Page
of 29